Article PDF
References
West KM . Epidemiology of diabetes and its vascular lesions. New York: Elsevier, 1978:415–20.
Klein R, Klein BEK, Moss SE, Cruickshanks KJ . The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care 1996;19:744–50.
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report no. 8. Ophthalmology 1981;88:583–600.
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology 1987;94:747–53.
Witkin SR, Klein R . Ophthalmologic care for persons with diabetes. JAMA 1984;251:2534–7.
Frank RN . On the pathogenesis of diabetic retinopathy: a 1990 update. Ophthalmology 1991;98:586–93.
Klein R . Retinopathy and other ocular complications in diabetes. In: Porte D Jr, Sherwin RS, editors. Ellenberg & Rifkin's diabetes mellitus. 5th ed. Stamford, CT: Appleton & Lange, 1996:938–40.
Klein R, Klein BEK, Moss SE, Cruickshanks KJ . The relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169–78.
The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.
Reichard P, Nilsson B-Y, Rosenqvist U . The effects of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304–9.
Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomised prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17.
UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. UKPDS 33. Lancet 1998;352:837–53.
Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL . Characterisation of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43:1122–9.
Brownlee M, Cerami A, Cerami A Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315–21.
Frank RN, Keirn RJ, Kennedy A, Frank KW . Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci 1983;24:1519–24.
Tilton RG, Chang K, Hasan KS, et al. Prevention of dysfunction by guanidines: inhibition of nitric oxide synthetase versus advanced glycosylated end-product formation. Diabetes 1993;42:221–32.
Giugliano D, Cerellio A, Paolisso G . Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257–65.
Clermont AC, Aiello LP, Mori F, et al. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:443–6.
American Diabetes Association. Position statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1995;18(Suppl 1):8–15.
ETDRS Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985;103:1796–806.
Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290–1.
International Diabetes Federation. Diabetes care and research in Europe: the Saint Vincent's Declaration. Diabet Med 1990;7:360.
Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991;29:20–39.
Javitt JC, Aiello LP . Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164–9.
Crijns H . Diabetic retinopathy: a cost-effectiveness analysis of ophthalmoscopy and photocoagulation [thesis]. Erasmus University, Amsterdam, 1993.
Chaturvedi N, Sjolie A-K, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998;351:28–31.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. BMJ 1998;317:703–13.
Savage S, Johnson NL, Estacio RO, et al, The ABCD [Appropriate Blood Pressure Control in Diabetes] Trial: rationale and design of a trial of hypertension control (moderate or intensive) in Type II diabetes. Online Journal of Current Clinical Trials. Doc no. 104, 1993.
The National Eye Health Education Program. From vision research to eye health education: planning the partnership. Bethesda, Md: National Institutes of Health, 1990. Available from National Institutes of Health, Box 20/20, Bethesda, MD 20892, USA.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, R. Diabetic retinopathy: An end of the century perspective. Eye 13, 133–135 (1999). https://doi.org/10.1038/eye.1999.39
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.39